A study for a 66 year old woman who takes Trulicity - from FDA reports

1,292 females aged 66 (±5) who take the same drug are studied. This is a personalized study for a 66 year old female patient who has Diabetes. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Dec, 05, 2018

1,292 females aged 66 (±5) who take Trulicity are studied.

Number of reports submitted per year:

Trulicity for a 66-year old woman.

Information of the patient in this study:

  • Age: 66
  • Gender: female
  • Conditions: Diabetes
  • Drugs taken:
    • Trulicity (dulaglutide)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Nausea (feeling of having an urge to vomit)
  2. Nausea and vomiting
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Lactic acidosis (low ph in body tissues)
  5. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  6. Abdominal pain upper
  7. Indigestion
  8. Weight decreased
  9. Blood glucose increased
  10. Pancreatitis (inflammation of pancreas)
1 - 6 months:
  1. Blood glucose increased
  2. Nausea (feeling of having an urge to vomit)
  3. Diarrhea
  4. Nausea and vomiting
  5. Pancreatitis (inflammation of pancreas)
  6. Weight decreased
  7. Abdominal pain
  8. Rashes (redness)
  9. Glycosylated haemoglobin increased
  10. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
6 - 12 months:
  1. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  2. Ischaemic cerebral infarction (ischemic stroke resulting from a disturbance in the blood vessels supplying blood to the brain)
  3. General physical health deterioration (weak health status)
  4. Blood glucose increased
  5. Glycosylated haemoglobin increased
  6. Arthropathy
  7. High blood pressure
  8. Eosinophil count increased
  9. Back pain
  10. Accidental overdose (therapeutic agent)
1 - 2 years:
  1. Lipase increased
  2. Nausea and vomiting
  3. Abdominal pain upper
  4. Glycosylated haemoglobin increased
  5. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  6. Hepatocellular injury (liver injury)
  7. Blood glucose increased
  8. Pancreatitis acute (sudden inflammation of pancreas)
  9. Drug ineffective
  10. Weight decreased
2 - 5 years:
  1. Stress and anxiety
  2. Night sweats (sweating in night)
  3. Blood glucose increased
  4. Insomnia (sleeplessness)
  5. Feeling jittery
  6. Pancreatitis (inflammation of pancreas)
  7. White blood cell count increased
  8. Gallbladder disorder
  9. Type 1 diabetes
  10. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
5 - 10 years:
10+ years:
not specified:
  1. Blood glucose increased
  2. Nausea (feeling of having an urge to vomit)
  3. Injection site pain
  4. Nausea and vomiting
  5. Injection site haemorrhage (bleeding from injection site)
  6. Diarrhea
  7. Weight decreased
  8. Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
  9. Fatigue (feeling of tiredness)
  10. Injection site bruising

Top conditions involved for these people *:

  1. Type 2 Diabetes : 804 people, 62.23%
  2. High Blood Pressure : 50 people, 3.87%
  3. High Blood Cholesterol : 29 people, 2.24%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 1.47%
  5. Depression : 14 people, 1.08%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 13 people, 1.01%
  7. Thyroid Diseases : 13 people, 1.01%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 0.77%
  9. Glycosylated Haemoglobin Increased : 9 people, 0.70%
  10. Weight Decreased : 8 people, 0.62%

Top co-used drugs for these people *:

  1. Metformin (397 people, 30.73%)
  2. Lantus (111 people, 8.59%)
  3. Humalog (70 people, 5.42%)
  4. Levemir (62 people, 4.80%)
  5. Novolog (46 people, 3.56%)
  6. Amlodipine (38 people, 2.94%)
  7. Invokana (38 people, 2.94%)
  8. Jardiance (37 people, 2.86%)
  9. Januvia (35 people, 2.71%)
  10. Vitamin D (27 people, 2.09%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!